Trial of a Supplemental Dose of Four Poliovirus Vaccines

Abstract

A supplemental dose of IPV has excellent immunogenicity and leads to increases in the titer of antibodies against type 3 poliovirus, whereas supplemental doses of the oral vaccines do not have these effects.